Prevalence of chronic gastritis has markedly declined in developed populations during the
past decades. However, chronic gastritis is still one of the most common serious pandemic …

Gastric cancer is the fourth most common malignancy and the second leading cause of
cancer-related death worldwide. 1 Although the incidence of gastric cancer in North America …

Our study investigated the relationship between gastric cancer development and activity of
Helicobacter pylori‐associated chronic gastritis or the resulting chronic atrophic gastritis …

The literature on the clinicopathologic characteristics of tumoral intraepithelial neoplasms
(neoplastic polyps) of the gallbladder (GB) is fairly limited, due in part to the variability in …

Mechanistic evidence linking chromosomal aberration (CA) to early stages of cancer has
been recently supported by the results of epidemiological studies that associated CA …

Carcinoma of the stomach is one of the most prevalent cancer types in the world. Although
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …

Gastric cancer remains a global killer with a shifting burden from the developed to the
developing world. The cancer develops along a multistage process that is defined by distinct …

Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although
surgical resection is a potentially curative approach for localized cases of GC, most cases of …

Background: Polymorphisms of interleukin-1B (IL1B) and its receptor antagonist (IL1RN)
genes have been inconsistently associated with gastric cancer risk. We examined these …

Background Cancerous inhibitor of protein phosphatase 2A (CIP2A) is a recently identified
human oncoprotein that stabilizes the c-Myc (MYC) protein. However, the clinical relevance …